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N-Nitroso+phenyl+lactam has been found to be a specific inhibitor of p-lactamase. N-Nitroso-a-phenyl+lactam, by 
contrast, was virtually ineffective although a transient inhibition of short duration was observed. The acyl enzyme derived 
from the B-phenyl isomer is presumably involved in a cross-linking reaction, whereas that from the a-phenyl isomer was 
quenched by spontaneous hydrolysis without formation of a covalent bond. No inhibitory effect of the B-phenyl isomer 
on chymotrypsin has been observed. 
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1. INTRODUCTION 2.2. Synthesis of N-nitroso-&phenyl;B-lactam (I)
A number of fl-lactamase inhibitors, either syn- 
thetic or natural, have been reported [ 11; several of 
them are applied in the clinical field. These in- 
hibitors are mostly classified as ‘mechanism- 
based’. Design of inhibitors of this category seems 
most promising for enzymes having large turnover 
numbers, such as ,&lactamase. N-Nitrosod-lactam 
was proposed as a mechanism-based inhibitor for 
chymotrypsin [2]. It was observed that the en- 
zymatic hydrolysis of the lactam ring initiates 
spontaneous formation of a carbonium cation 
capable of covalently labeling the enzyme. This 
report prompted us to study the behavior of N- 
nitroso-&lactams (I and II) with ,&lactamases. 
,&Phenyl-@actam (I’) was synthesized as in [4]. Nitrosoa- 
tion of I’ was carried out as reported [5]. Recrystallized from 
n-hexane. Pale yellow fine needles, m.p. 78.5%82.5”C (46% 
yield). Anal. Calcd. for C9HsNsOz: C, 61.36; H, 4.58; N, 
15.90. Found: C, 61.37; H, 4.59; N, 15.82. 
2.3. Synthesis of N-nitroso-cu-phenyl,B-lactam 01) 
Nitrosoation of n-phenyl-fi-lactam (II’) 16) was carried out as 
above. Pate yellow viscous oil was obtained (25% yield). JR 
(nujol): 1810, 1740, 1640 cm-‘. TLC on silica gel (benzene) 
gave a single spot. 
2.4. Inhibition of Slactamase with I 
2. METHODS AND RESULTS 
In fig.2 the residual activity of the enzyme as a function of 
the incubation period with I was shown. The inactivation reac- 
tion was completed within a minute (the limit of the experimen- 
tal procedure). At pH 5.5,7 and 8, the extent of the inactivation 
was 40, 81 and 75%, respectively. Readdition of I caused fur- 
ther inhibition and nearly complete inactivation. The inactiva- 
tion reaction was prevented by the presence of cephalosporin C, 
an active site specific compound. Both I’ and the hydrolysate 
of I did not cause inhibition (table 1). 
2.1. Materials 
PADAC fl-lactamase substrate, 7-(thienyl-2-acetamide)-3- 
[2-(4-N,N-dimethylaminophenylazo)pyridinium methyl]-3- 
cepham+carboxylic acid [3], was a product from Hoechst, 
Calbiochem. Cephalosporin C was obtained from Sigma. 
Benzoyl-L-tyrosine-p-nitro-anilide (BTNA) was obtained from 
Peptide Research Foundation, Osaka. Chymotrypsin was a 
Cooper Biomedical product. 
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Fig. 1. Structure of &lactam derivatives, 
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Fig.2. Time course of inhibition of B. cereus,&lactamase by I. 
@-Lactamase (100 nM) was incubated with I(1 mM) at 25°C in 
0.1 M citrate, pH 5.5 (O), 0.1 M phosphate, pH 7.0 (0) and 
0.05 M Tris, pH 8.0 (0). Effect of readdition of I (total 
concentration, 2 mM) (m). Control experiment: in the absence 
of I at pH 7 (A). The residual activity was determined using 
PADAC substrate in 0.1 M phosphate at pH 7.0, 25°C 
monitoring the absorbance at 570 nm taking de 4000. To 3 ml 
of PADAC solution (50pM), 50~1 aliquot of the incubate 
(containing 5 x lo-‘* mol of enzyme) was added. 
Concentration of fl-lactamase was determined based on the 
reported rate constant, 3500 SK’ for penicillin G at pH 7.0 [lo]. 
2.5. Interaction of II with ,&lactamase 
Analysis was carried out by a direct measurement method: 
the hydrolysis of PADAC substrate was determined in the 
presence of II in situ. The velocity change was analyzed as a 
function of the incubation period. As shown in fig.3, com- 
Table 1 
Effect of inhibitors and related compounds on @-lactamase 
activitya 
Inhibitor Catalytic activity (o/o) 
Noneb 100 
I 20 
I’ 100 
I + cephalosporin Cd 102 
I’ 100 
a Enzyme (1 nM) was incubated with I or I’ (1 mM) for 15 min 
at 25”C, pH 7 (0.1 M phosphate containing 0.5% dimethyl 
sulfoxide) 
b Control experiment 
’ Hydrolysate of I was added. Prior to the addition, I was 
treated for 10 min at 100°C in 0.1 M phosphate buffer, pH 
7.0 
d Enzyme was incubated for 15 min with cephalosporin C 
(50 mM) prior to the addition of I 
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Fig.3. Time course of interaction of B. cereus,&lactamase byII. 
The hydrolytic rate of PADAC lactamase substrate (50 pM) in 
the presence of enzyme (100 nM) and II (1 mM) in situ was 
determined in 0.1 M phosphate at pH 7.0, 25°C (0). In the 
absence of II (0). 
pound II exhibited transient inhibition; rapid decrease and slow 
recovery of activity. 
2.6. Interaction of 1 with chymotrypsin 
Irreversible inactivation of chymotrypsin did not happen with 
I. The observation is quite different from that of ,&lactamase. 
In the same manner as described in section 2.4, the effect of 
compounds I (100 CM) on chymotrypsin (100 nM) was analyzed 
using BTNA [7] as a substrate in 0.05 M Tris, pH 8.0, at 25°C. 
Transient inhibition of chymotryptic activity, essentially iden- 
tical to that of fig.3, was observed. 
2.7. Inhibition of ,&Iactamases of different origin 
The extent of inhibition is dependent on the enzyme source 
(table 2). I is superior to one of the most potent inhibitors, 
clavulanic acid, toward E. coli TEM R+ and P. aeruginosa U 
3 1. P-Lactamases used are those cited in the literature [8]. 
Table 2 
Inhibition of Blactamases from various origins 
Enzyme source % inhibitiona 
I Clavulanic acid 
B. cereus <5 74 
P. vulgaris 30 90 
E. cloacae GN 4413 44 34 
E. coli TEM R+ 50 <5 
P. aeruginosa U 31 91 37 
a Enzyme was incubated with inhibitor (10 mM) in 0.05 M 
phosphate buffer at pH 7.0, 25°C for 10 min. Residual 
activity of the incubate was measured using nitrocefin as a 
substrate [1 I] 
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3. DISCUSSION 
I interacts presumably to give an acyl enzyme 
and subsequently brings about covalent modifica- 
tion of the enzyme. The formation of the covalent 
bond was suggested from the fact that no enzyme 
activity was recovered after tr~tment of the in- 
hibited enzyme with 1 M hydroxylamine. By con- 
trast, acyl-@-lactamase from II might be 
hydrolyzed spontaneously without formation of 
the covalent bond. Chemically both I and II are 
comparable. The rate constant for spontaneous 
hydrolysis of II (0.063 s-i at pH 7.0) was not much 
different from that of I (0.14 s-l at pH 7.0). The 
structural difference between acyl enzymes from I 
and II may cause the difference in the proximity of 
the respective reactive species to the enzyme 
nucleophile. Discrimination of I ‘between 
chymotrypsin and ,&lactamase may be caused by 
structural differences of the respective active sites 
interacting with the reactive species from 1. 
In the search for new @-lactam antibiotics, con- 
siderable numbers of antibiotics carrying a novel 
ring system have been discovered. Monocyclic ,8- 
lactam, monobactam [9] is just one example which 
encouraged us to design nitroso-P-lactams as possi- 
ble inhibitors of ,&lactamase. Although compound 
I has been shown to be effective in vitro, its stabili- 
ty in aqueous media is not sufficient enough for 
practical purposes. Nitroso-@-lactam, however, 
could be proposed as a new key compound for ,& 
lactamase inhibitors. Further work on the im- 
provement of the stability by designing ap- 
propriate substituents is in progress. 
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